全球血液學診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計血液診斷市場將從 2025 年的 44 億美元成長到 2034 年的 82.1 億美元，2026 年至 2034 年的複合年成長率為 7.18%。

由於對精確血球計數和疾病檢測的需求不斷成長，全球血液診斷市場正經歷顯著成長。血液分析儀和試劑廣泛應用於醫院和診斷實驗室，用於識別貧血、感染疾病和血液癌症等疾病。醫療保健服務的普及和常規健康檢查項目的擴展，也推動了市場的穩定成長。

關鍵成長要素包括慢性病和感染疾病病率的上升、自動化分析儀的技術進步以及檢查室自動化的發展。診斷準確性的提高和結果報告的快速反應提升了臨床決策的品質。新興國家醫療基礎設施的擴張也促進了市場成長。

隨著個人化醫療和預防醫學的日益普及，市場前景依然強勁。先進分析技術和人工智慧解讀工具的整合將提升診斷效率。檢查室現代化改造投資的增加預計將創造新的機會。隨著全球醫療保健標準的提升，血液診斷市場預計將持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球血液學診斷市場：依產品分類

• 市場分析、洞察與預測
• 分析設備（分析儀、流式細胞儀等）
• 耗材（試劑、染色劑及其他配件）

第5章：全球血液學診斷市場：依檢測方式分類

• 市場分析、洞察與預測
• 血球計數
• 血小板功能
• 血紅素
• 血球容積比

第6章：全球血液學診斷市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 診斷實驗室
• 其他

第7章 全球血液學診斷市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和分銷通路合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott
  • Beckman Coulter Inc
  • Sysmex Corporation
  • Horiba
  • Bio-Rad Lboratories
  • Siemens Healthineers AG
  • F. Hoffmann-La Roche Ltd
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd
  • Nihon Kohden Corporation
  • EKF Diagnostics

The Hematology Diagnostics Market size is expected to reach USD 8.21 Billion in 2034 from USD 4.40 Billion (2025) growing at a CAGR of 7.18% during 2026-2034.

The Global Hematology Diagnostics Market has experienced significant growth due to rising demand for accurate blood testing and disease detection. Hematology analyzers and reagents are widely used in hospitals and diagnostic laboratories for identifying conditions such as anemia, infections, and blood cancers. Increasing healthcare access and routine health screening programs have supported steady market expansion.

Major drivers include growing prevalence of chronic and infectious diseases, technological advancements in automated analyzers, and rising laboratory automation. Improved diagnostic accuracy and faster turnaround times enhance clinical decision-making. Expanding healthcare infrastructure in emerging economies further contributes to market growth.

Future prospects remain strong as personalized medicine and preventive healthcare gain traction. Integration of advanced analytics and AI-based interpretation tools will enhance diagnostic efficiency. Growing investments in laboratory modernization will create new opportunities. As global healthcare standards improve, the hematology diagnostics market is expected to witness sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Instrument (Analyzers, Flow Cytometers, Others)
• Consumables (Reagents, Stains, Others Accessories)

By Test

• Blood count
• Platelet function
• Hemoglobin
• Hematocrit

By End Use

• Hospitals
• Diagnostic labs
• Others

COMPANIES PROFILED

• Abbott, Beckman Coulter Inc, Sysmex Corporation, Horiba, BioRad Lboratories, Siemens Healthineers AG, F HoffmannLa Roche Ltd, Shenzhen Mindray BioMedical Electronics Co Ltd, Nihon Kohden Corporation, EKF Diagnostics

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEMATOLOGY DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Instrument (Analyzers, Flow Cytometers, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Consumables (Reagents, Stains, Others Accessories) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEMATOLOGY DIAGNOSTICS MARKET: BY TEST 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test
• 5.2. Blood count Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Platelet function Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hemoglobin Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Hematocrit Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEMATOLOGY DIAGNOSTICS MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic labs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEMATOLOGY DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Test
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Test
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Test
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Test
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Test
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HEMATOLOGY DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott
  • 9.2.2 Beckman Coulter Inc
  • 9.2.3 Sysmex Corporation
  • 9.2.4 Horiba
  • 9.2.5 Bio-Rad Lboratories
  • 9.2.6 Siemens Healthineers AG
  • 9.2.7 F. Hoffmann-La Roche Ltd
  • 9.2.8 Shenzhen Mindray Bio-Medical Electronics Co. Ltd
  • 9.2.9 Nihon Kohden Corporation
  • 9.2.10 EKF Diagnostics